Novel treatment for myocardial infarction uses nanovesicles to modulate immune response
Myocardial infarction, the number one cause of sudden death in adults and the number two cause of death in Korea, is a deadly disease with an initial mortality rate of 30%, and about 5%–10% of patients die even if they ...
